Targovax to present at 5th Neoantigen Summit Europe in Amsterdam
Oslo, 26 April 2022 – Targovax ASA announces that members of its executive management team are invited for oral presentations and a panel discussion at the 5[th] Neoantigen Summit Europe in Amsterdam 27-28 April.Presentation: Uncovering the Benefits of Personalized Vaccines in a Clinical SettingPresenter: Dr. Erik Digman Wiklund (CEO)Date: 27 April 2022Time: 10:00 CET Presentation: Clinical Combination Strategies with Oncolytic Vaccines in Solid TumorsPresenter: Dr. Victor Levitsky (CSO)Date: 28 April 2022Time: 15:30 CET Panel Discussion: Evaluating Combination Therapies